Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $385,548 - $420,714
-2,648 Reduced 3.79%
67,305 $10.5 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $3.3 Million - $3.69 Million
-21,169 Reduced 23.23%
69,953 $10.9 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $14.1 Million - $15.1 Million
91,122 New
91,122 $15.1 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $13.5 Million - $16.1 Million
89,282 New
89,282 $13.8 Million
Q3 2022

Nov 18, 2022

BUY
$161.33 - $179.52 $6.65 Million - $7.39 Million
41,189 New
41,189 $6.73 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $6.47 Million - $7.15 Million
-38,450 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $6.08 Million - $6.91 Million
38,450 New
38,450 $6.82 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Power Corp Of Canada Portfolio

Follow Power Corp Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Power Corp Of Canada with notifications on news.